Black cohosh: A cause of abnormal postmenopausal liver function tests

Climacteric

Volumn 11, Issue 1, 2008, Pages 84-88

  Joy, D ^a   Joy, J ^b   Duane, P ^c  

^a PRINCE PHILIP HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c MORRISTON HOSPITAL   (United Kingdom)

Author keywords

Black cohosh; Herbal remedies; Hormone replacement therapy; Liver toxicity

Indexed keywords

CIMICIFUGA RACEMOSA EXTRACT;

ABNORMAL LABORATORY RESULT; ADULT; ARTICLE; CASE REPORT; CIMICIFUGA RACEMOSA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; DRUG SAFETY; EPIGASTRIC PAIN; FEMALE; FOLLOW UP; HEADACHE; HERBAL MEDICINE; HUMAN; LIVER FUNCTION TEST; LIVER TOXICITY; MENOPAUSAL SYNDROME; POSTMENOPAUSE; PRIORITY JOURNAL; SIDE EFFECT; SYMPTOM;

CIMICIFUGA; COMPLEMENTARY THERAPIES; FEMALE; HOT FLASHES; HUMANS; LIVER; LIVER FUNCTION TESTS; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; POSTMENOPAUSE; SAFETY;

EID: 38349051228     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130701864056     Document Type: Article

References (27)

1. Royal College of Obstetricians and Gynaecologists. Menopause and hormone replacement: study group recommendations. http://www.rcog.org.uk/index.asp? PageID=310. 2004 Dec
2. British Menopause Society Consensus Statements: Alternative and complementary therapies. http://www.thebms.org.uk/statementcontent.php?id=2
3. Medicines and Healthcare products Regulatory Agency. Press release: MHRA action on safety concerns over black cohosh and liver injury. http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&ssDocName= CON2024116&ssSourceNodeId=663&ssTargetNodeId=389
4. Wuttke W, Raus K, Gorkow C. Efficacy and tolerability of the black cohosh (Actaea racemosa) ethanolic extract BNO 1055 on climacteric complaints: a double-blind, placebo- and conjugated estrogens-controlled study. Maturitas 2006;55(Suppl 1):S83-91
5. Seidlova-Wuttke D, Thelen P, Wuttke W. Inhibitory effects of a black cohosh (Cimicifuga racemosa) extract on prostate cancer. Planta Med 2006;72:521-6
6. Wuttke W, Rimoldi G, Christoffel J, Seidlova-Wuttke D. Plant extracts for the treatment of menopausal women: Safe? Maturitas 2006;55(Suppl 1):S92-100
7. Burdette JE, Liu J, Chen SN, et al. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem 2003;51:5661-70
8. Jarry H, Metten M, Spengler B, Christoffel V, Wuttke W. In vitro effects of the Cimicifuga racemosa extract BNO 1055. Maturitas 2003;44(Suppl 1):S31-8
9. Fabricant DS, Nikolic D, Lankin DC, et al. Cimipronidine, a cyclic guanidine alkaloid from Cimicifuga racemosa. J Nat Prod 2005;68:1266-70
10. Woo KC, Park YS, Jun DJ, et al. Phytoestrogen cimicifugoside- mediated inhibition of catecholamine secretion by blocking nicotinic acetylcholine receptor in bovine adrenal chromaffin cells. J Pharmacol Exp Ther 2004;309:641-9
11. Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneicke-von Zepelin HH. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol 2005;105:1074-83
12. Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 2006;145:869-79
13. Pockaj BA, Gallagher JG, Loprinzi CL, et al. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG trial N01CC1. J Clin Oncol 2006;24:2836-41
14. Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med 2006;166:1453-65
15. Reed SD, Newton KM, Lacroix AZ, Grothaus LC, Grieco VS, Ehrlich K. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: The Herbal Alternatives for Menopause (HALT) study. Menopause 2007 July 6; Epub ahead of print
16. Cheema D, Coomarasamy A, El-Toukhy T. Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review. Arch Gynecol Obstet 2007;276:463-9
17. Whiting PW, Clouston A, Kerlin P. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust 2002;177:440-3
18. Lynch CR, Folkers ME, Hutson WR. Fulminant hepatic failure associated with the use of black cohosh: a case report. Liver Transplant 2006;12:989-92
19. Lontos S, Jones RM, Angus PW, Gow PJ. Acute liver failure associated with the use of herbal preparations containing black cohosh. Med J Aust 2003;179:390-1
20. Levitsky J, Alli TA, Wisecarver J, Sorrell MF. Fulminant liver failure associated with the use of black cohosh. Dig Dis Sci 2005;50:538-9
21. Dog TL, Powell KL, Weisman SM. Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief. Menopause 2003;10:299-313
22. Huntley A. The safety of black cohosh (Actaea racemosa, Cimicifuga racemosa). Expert Opin Drug Saf 2004;3:615-23
23. Tsukamoto S, Aburatani M, Ohta T. Isolation of CYP3A4 inhibitors from the black cohosh (Cimicifuga racemosa). Evid Based Complement Alternat Med 2005;2:223-6
24. Gurley BJ, Gardner SF, Hubbard MA, et al. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging 2005;22:525-39
25. Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther 2005;77:415-26
26. Huntley A. Drug-herb interactions with herbal medicines for menopause. J Br Menopause Soc 2004;10:162-5
27. Herr SM, Eazard E, Veronica SLY, eds. Herb-drug Interaction Handbook, 2nd edn. Nassau, NY: Church Street Books, 2002